Literature DB >> 11483319

Late radiation effects to the rectum and bladder in gynecologic cancer patients: the comparison of LENT/SOMA and RTOG/EORTC late-effects scoring systems.

Y Anacak1, D Yalman, Z Ozsaran, A Haydaroğlu.   

Abstract

PURPOSE: To test the correlation of LENT/SOMA and RTOG/EORTC late-effect scales for rectum and bladder, 116 cases with gynecologic malignancies that were treated with radiotherapy were assessed with both scales. METHODS AND MATERIALS: All cases had been treated at least 6 months before the date of assessment with external beam radiotherapy (50--54 Gy to midline) and 1--2 fractions of HDR brachytherapy (2 x 8.5 Gy to point-A for 32 inoperable cases; 1 x 9.25 Gy to 5--9 mm from the ovoid surface for 84 postoperative cases). The patients were questioned with both scales, and the correlation between the two scales was analyzed by Spearman's rho (rank correlation) test.
RESULTS: There were 64 cases with uterine cervix carcinoma and 52 cases with endometrium carcinoma, The overall (external + brachy) doses to ICRU points were 57.8 +/- 3.8 Gy for rectum and 59.3 +/- 4.9 Gy for bladder. The statistical analysis of LENT/SOMA and RTOG/EORTC scales revealed a very good correlation for rectum (r = 0.81; p < 0.01) and a good correlation for bladder (r = 0.72; p < 0.01).
CONCLUSION: The LENT/SOMA system is a further step on the reporting of late radiation effects. Some modifications will improve its precision, and multicentric randomized studies are needed to test its validity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11483319     DOI: 10.1016/s0360-3016(01)01527-9

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  8 in total

1.  Canadian Urological Association Best Practice Report: Diagnosis and management of radiation-induced hemorrhagic cystitis.

Authors:  George Goucher; Fred Saad; Himu Lukka; Anil Kapoor
Journal:  Can Urol Assoc J       Date:  2019-02       Impact factor: 1.862

2.  Late GI and bladder toxicities after radiation for uterine cancer.

Authors:  Rafael Samper-Ternent; Dong Zhang; Yong-Fang Kuo; Sandra Hatch; Jean Freeman
Journal:  Gynecol Oncol       Date:  2010-11-16       Impact factor: 5.482

3.  An observational trial to establish the effect of hyperbaric oxygen treatment on pelvic late radiation tissue injury due to radiotherapy.

Authors:  James Andren; Michael H Bennett
Journal:  Diving Hyperb Med       Date:  2020-09-30       Impact factor: 0.887

4.  Health-related quality of life and late morbidity in concurrent chemoradiation and radiotherapy alone in patients with locally advanced cervical carcinoma.

Authors:  Maaike J Berveling; Johannes A Langendijk; Jannet C Beukema; Marian J E Mourits; Anna K L Reyners; Elisabeth Pras
Journal:  J Gynecol Oncol       Date:  2011-09-28       Impact factor: 4.401

5.  Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects.

Authors:  D P Dearnaley; E Hall; D Lawrence; R A Huddart; R Eeles; C M Nutting; J Gadd; A Warrington; M Bidmead; A Horwich
Journal:  Br J Cancer       Date:  2005-02-14       Impact factor: 7.640

6.  A modified Inflammatory Bowel Disease questionnaire and the Vaizey Incontinence questionnaire are simple ways to identify patients with significant gastrointestinal symptoms after pelvic radiotherapy.

Authors:  F A Olopade; A Norman; P Blake; D P Dearnaley; K J Harrington; V Khoo; D Tait; C Hackett; H J N Andreyev
Journal:  Br J Cancer       Date:  2005-05-09       Impact factor: 7.640

7.  Research Value of Intensity Modulated Radiation Therapy in Alleviating Parotid Gland Function Injury in Patients with Stage N0 Nasopharyngeal Carcinoma from Physical and Dosimetric Aspects.

Authors:  Lirong Zheng; Hong Wang; Neng Yang; Fenglei Du; Lin Xiao; Gangfeng Wu
Journal:  Comput Math Methods Med       Date:  2022-07-11       Impact factor: 2.809

8.  Late rectal toxicity determined by dose-volume parameters in computed tomography-based brachytherapy for locally advanced cervical cancer.

Authors:  Yong-Chun Zhou; Li-Na Zhao; Ning Wang; Jing Hu; Xiao-Huan Sun; Ying Zhang; Jian-Ping Li; Wei-Wei Li; Jun-Yue Liu; Li-Chun Wei; Mei Shi
Journal:  Cancer Med       Date:  2016-01-24       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.